0001140361-17-011288.txt : 20170309 0001140361-17-011288.hdr.sgml : 20170309 20170309191146 ACCESSION NUMBER: 0001140361-17-011288 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170308 FILED AS OF DATE: 20170309 DATE AS OF CHANGE: 20170309 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER, INC. CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 BUSINESS PHONE: 512-777-3800 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE STREET 2: SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 FORMER COMPANY: FORMER CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Liang Samuel M. CENTRAL INDEX KEY: 0001618037 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 17679870 MAIL ADDRESS: STREET 1: 10910 DOMAIN DRIVE, SUITE 300 CITY: AUSTIN STATE: TX ZIP: 78758 4 1 doc1.xml FORM 4 X0306 4 2017-03-08 0 0000722723 HANGER, INC. HGR 0001618037 Liang Samuel M. 10910 DOMAIN DRIVE, SUITE 300 AUSTIN TX 78758 0 1 0 0 Executive Vice President* Common Stock 2017-03-08 4 A 0 22500 0 A 77292 D Represents a grant of time-based restricted stock under the Company's 2016 Omnibus Incentive Plan (the "Plan"), which vests to the extent of 25% annually beginning on March 8, 2018 and cumulatively vests to the extent of 25% each year thereafter. The restricted stock being reported does not include the contingent right of the reporting person to receive up to 22,500 additional performance shares under the Plan based on the achievement of certain performance targets for the fiscal year 2017. Includes (i) unvested restricted shares which total 22,500 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 8, 2018; (ii) unvested restricted shares which total 5,000 shares of stock from an initial grant of 5,000 shares of restricted stock that begins to vest on October 11, 2017; (iii) unvested restricted shares and fully vested shares totaling 22,500 shares of stock from an initial grant of 22,500 shares of restricted stock that begins to vest on March 7, 2017; (iv) unvested restricted shares and fully vested shares totaling 13,777 shares of stock from an initial grant of 13,777 shares of restricted stock made on March 6, 2015 and (v) unvested restricted shares and fully vested shares totaling 13,515 shares of stock from an initial grant of 14,745 shares of restricted stock made on May 19, 2014. Except as otherwise noted, all remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. * The reporting person is Executive Vice President of Hanger, Inc. and President and Chief Operating Officer of Hanger Prosthetics & Orthotics, Inc. /s/ Jessica Lochmann Allen, Attorney-in-Fact for Samuel M. Liang 2017-03-09